Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
NextCure, Inc. - Common Stock
(NQ:
NXTC
)
5.607
-0.073 (-1.28%)
Delayed Quote
Updated: 10:38 AM EDT, Oct 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NextCure, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference
November 26, 2024
From
NextCure
Via
GlobeNewswire
Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta
November 19, 2024
From
NextCure
Via
GlobeNewswire
NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results
November 07, 2024
From
NextCure
Via
GlobeNewswire
NXTC Stock Earnings: NextCure Beats EPS for Q4 2023
↗
March 21, 2024
NXTC stock results show that NextCure beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting
November 05, 2024
From
NextCure
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 28, 2024
Via
Benzinga
NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting
October 04, 2024
From
NextCure
Via
GlobeNewswire
NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024
September 16, 2024
From
NextCure
Via
GlobeNewswire
NXTC Stock Earnings: NextCure Misses EPS for Q2 2024
↗
August 01, 2024
NXTC stock results show that NextCure missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results
August 01, 2024
From
NextCure
Via
GlobeNewswire
NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
June 20, 2024
From
NextCure
Via
GlobeNewswire
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
May 30, 2024
From
NextCure
Via
GlobeNewswire
NXTC Stock Earnings: NextCure Misses EPS for Q1 2024
↗
May 02, 2024
NXTC stock results show that NextCure missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
May 02, 2024
From
NextCure
Via
GlobeNewswire
NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
April 24, 2024
From
NextCure
Via
GlobeNewswire
NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
April 08, 2024
Poster presentation highlights strong safety and pharmacokinetic profiles for LNCB74
From
NextCure
Via
GlobeNewswire
NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
April 04, 2024
From
NextCure
Via
GlobeNewswire
NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
NextCure
Via
GlobeNewswire
Wall Street’s Favorite Penny Stocks? 7 Names That Could Make You Filthy Rich
↗
March 23, 2024
The market is surging higher after dovish Fed comments. Here are seven of Wall Street’s favorite penny stocks that can help make you rich
Via
InvestorPlace
Topics
Economy
12 Health Care Stocks Moving In Friday's After-Market Session
↗
March 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
March 21, 2024
Via
Benzinga
NextCure Provides Business Update and Reports Full Year 2023 Financial Results
March 21, 2024
From
NextCure
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
March 06, 2024
Via
Benzinga
NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances
March 05, 2024
From
NextCure
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
February 16, 2024
Via
Benzinga
NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders
January 18, 2024
From
NextCure
Via
GlobeNewswire
NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury
December 21, 2023
From
NextCure
Via
GlobeNewswire
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
December 14, 2023
Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
December 14, 2023
Via
Benzinga
US Stocks Higher; Initial Jobless Claims Fall To 202,000
↗
December 14, 2023
U.S. stocks traded higher this morning, following the release of economic reports on Thursday. Following the market opening Thursday, the Dow traded up 0.24% to 37,180.82 while the NASDAQ rose 0.60% to...
Via
Benzinga
Topics
Stocks
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
